Search Results - "Jebavy, L"

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation by Martínez, C., Canals, C., Sarina, B., Alessandrino, E.P., Karakasis, D., Pulsoni, A., Sica, S., Trneny, M., Snowden, J.A., Kanfer, E., Milpied, N., Bosi, A., Guidi, S., de Souza, C.A., Willemze, R., Arranz, R., Jebavy, L., Hellmann, A., Sibon, D., Oneto, R., Luan, J.J., Dreger, P., Castagna, L., Sureda, A.

“…High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is the standard of care for patients with relapsed Hodgkin's lymphoma (HL)…”
Get full text

Evaluation of serum levels of selected cytokine receptors in adult B-cell precursor acute lymphoblastic leukemia and their association with prognostic factors and survival by Horacek, J M, Kupsa, T, Vanek, J, Jakl, M, Stajer, M, Jebavy, L, Zak, P

“…To evaluate serum levels of selected cytokine receptors in B-cell precursor acute lymphoblastic leukemia (B-ALL) and their association with acknowledged…”
Get more information

The first determination of Trichuris sp. from roe deer by amplification and sequenation of the ITS1-5.8S-ITS2 segment of ribosomal DNA by Salaba, O., Rylková, K., Vadlejch, J., Petrtýl, M., Scháňková, Š., Brožová, A., Jankovská, I., Jebavý, L., Langrová, I.

“…Trichuris nematodes were isolated from roe deer ( Capreolus capreolus ). At first, nematodes were determined using morphological and biometrical methods…”
Get full text

Biochip array technology and evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute myeloid leukemia by Horacek, J M, Kupsa, T, Vasatova, M, Jebavy, L, Zak, P

“…Evaluation of serum levels of 17 cytokines and 5 adhesion molecules in patients with newly diagnosed acute myeloid leukemia (AML) and in healthy subjects using…”
Get more information

Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity by Horacek, J.M., Tichy, M., Pudil, R., Jebavy, L.

Get full text

Olfactory sensitivity in mammalian species by Wackermannová, M, Pinc, L, Jebavý, L

“…Olfaction enables most mammalian species to detect and discriminate vast numbers of chemical structures called odorants and pheromones. The perception of such…”
Get full text

Evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute lymphoblastic leukemia using biochip array technology by Horacek, J M, Kupsa, T, Vasatova, M, Jebavy, L, Zak, P

“…Evaluation of serum levels of 17 cytokines and 5 adhesion molecules in patients with acute lymphoblastic leukemia (ALL) and in healthy subjects using biochip…”
Get more information

The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia by Horacek, J M, Vasatova, M, Tichy, M, Pudil, R, Jebavy, L, Maly, J

“…Monitoring of cardiotoxicity of conventional and high-dose chemotherapy (HD-CT) with multiple biomarkers of cardiac injury - glycogen phosphorylase BB (GPBB),…”
Get more information

Assessment of anthracycline-induced cardiotoxicity with biochemical markers by Horacek, J M, Pudil, R, Jebavy, L, Tichy, M, Zak, P, Maly, J

“…Assessment of acute and chronic cardiotoxicity of anthracyclines in patients treated for acute leukemia (AL) with biochemical markers - "N-terminal pro brain…”
Get more information

Assessment of anthracycline-induced cardiotoxicity with electrocardiography by Horacek, J M, Jakl, M, Horackova, J, Pudil, R, Jebavy, L, Maly, J

“…Monitoring of anthracycline-induced cardiotoxicity with electrocardiography (ECG) and comparing ECG changes with findings on echocardiography (ECHO). A total…”
Get more information

Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies by Horacek, J M, Jebavy, L, Ulrychova, M, Tichy, M, Pudil, R, Zak, P, Maly, J

Get full text

Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines by Pudil, R, Horacek, J M, Strasova, A, Jebavy, L, Vojacek, J

“…To analyze the very early changes of diastolic LV function during and after chemotherapy (CT) in patients with newly diagnosed acute leukemia. 26 patients with…”
Get more information

Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation by Horacek, J.M., Tichy, M., Jebavy, L., Ulrychova, M., Pudil, R.

Get full text

Anthracycline therapy can induce very early increase in QT dispersion and QTc prolongation by Pudil, R, Horacek, J.M, Horackova, J, Jebavy, L, Vojacek, J

Get full text

Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia by Horacek, J M, Jebavy, L, Vasatova, M, Pudil, R, Tichy, M, Jakl, M, Maly, J

“…The aim of the presented study was to assess plasma glycogen phosphorylase BB (GPBB) concentrations in acute leukemia patients treated with anthracycline…”
Get full text

Global quality of life in patients who have undergone the hematopoietic stem cell transplantation: finding from transversal and retrospective study by Slovacek, L, Slovackova, B, Jebavy, L

“…To analyse the factors which influence global quality of life in patients after the hematopoietic stem cell transplantation at the Department of Clinical…”
Get more information

Cardiovascular changes associated with infusion of hematopoietic cell grafts in oncohematological patients -- impact of cryopreservation with dimethylsulfoxide by Horacek, J M, Jebavy, L, Jakl, M, Zak, P, Mericka, P, Maly, J

“…Dimethylsulfoxide (DMSO) is the most frequently used agent for hematopoietic cell (HC) graft cryopreservation. This study aimed to monitor blood pressure and…”
Get more information

Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia by Horacek, J M, Tichy, M, Jebavy, L, Pudil, R, Ulrychova, M, Maly, J

“…To assess cardiac toxicity of anthracycline treatment with six biomarkers of cardiac injury: myoglobin, creatine kinase MB (CK-MB mass), cardiac troponin T…”
Get more information

Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia by Jakl, M, Horacek, J.M, Jebavy, L, Pudil, R

Get full text

The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia by Horácek, J M, Pudil, R, Tichý, M, Jebavý, L, Strasová, A, Praus, R, Zák, P, Malý, J

“…Cardiotoxicity is a serious and relatively frequent complication of anti-tumorous treatment. Anthracyclines represent the greatest risk. Biochemical markers of…”
Get more information